{"count":2,"index":{"built_at":"2026-07-27T16:37:17.943683+00:00","public_records":55311,"revision":"4d583ee400e1200c2937dbe3"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: CYP2D6 in the context of Fruchtbarkeit"},"results":[{"answer":"CYP2D6 is a key phase I drug-metabolizing enzyme involved in the breakdown of many medications and endogenous substances, including steroid hormones. In the context of fertility, CYP2D6 is discussed mainly regarding its role in metabolizing estrogens, progestins, and SSRIs sometimes used in fertility treatments. However, evidence for a direct impact of CYP2D6 variants on fertility is weak. Some association studies suggest a possible role in hormone regulation, but effect sizes are small and results inconsistent. Clinical relevance for individual fertility outcomes is unclear. A DNA test for CYP2D6 cannot be recommended as a diagnostic or predictive tool for fertility issues. Established fertility assessments (hormone panels, cycle tracking, semen analysis) remain the standard. The evidence is mechanistic/pharmacogenetic, not based on direct fertility endpoints. Consumers should be cautious about overinterpreting such genetic results.","area":"gesundheit","canonical_id":"gesundheit:canonical-8da92748a3ab0ae41f565bfb","id":"public-1b4dea72843a603afb7e4d73","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: CYP2D6 in the context of Fruchtbarkeit","score":23.74211461,"snippet":"CYP2D6 is a key phase I drug-metabolizing enzyme involved in the breakdown of many medications and endogenous substances, including steroid hormones. In the context of fertility, CYP2D6 is discussed mainly regarding its role in metabolizing estrogens, progestins, and SSRIs sometimes used in fertility treatments. However, evidence for a direct impact of CYP2D6 variants on fertility is weak. Some association studies suggest a possible role in hormone regulation, but effect sizes are small and results inconsistent. Clinical relevance for individual fertility outcomes is unclear. A DNA test for CYP2D6 cannot be recommended as a diagnostic or predictive tool for fertility issues. Established fert","sources":[],"title":"Evidence check: CYP2D6 in the context of Fruchtbarkeit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-1b4dea72843a603afb7e4d73/evidence-check-cyp2d6-in-the-context-of-fruchtbarkeit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The pharmacogenetics Medicheck in the context of fertility claims to identify genetic variants that affect the metabolism of hormone or fertility drugs. However, the scientific evidence is limited. While some SNPs in CYP2C19, CYP2D6, or FSH receptor genes may modulate the efficacy of clomiphene, letrozole, or gonadotropins, effect sizes are generally small and clinical relevance remains unclear. Most studies are mechanistic or observational; randomized controlled trials are lacking. Commercial tests often overlook polygenicity and environmental factors. A positive result should not lead to self-adjustment of medication. Pharmacogenetics in reproductive medicine is an emerging field but not yet standard practice. Medical supervision is essential. The evidence is rated as 'mixed': there are mechanistic and GWAS data, but insufficient validation for routine use.","area":"gesundheit","canonical_id":"gesundheit:canonical-4583393248669dc805c01413","id":"public-1f5369b593cc2006e97d52f1","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Pharmakogenetik Medicheck in the context of Fruchtbarkeit","score":21.88005996,"snippet":"The pharmacogenetics Medicheck in the context of fertility claims to identify genetic variants that affect the metabolism of hormone or fertility drugs. However, the scientific evidence is limited. While some SNPs in CYP2C19, CYP2D6, or FSH receptor genes may modulate the efficacy of clomiphene, letrozole, or gonadotropins, effect sizes are generally small and clinical relevance remains unclear. Most studies are mechanistic or observational; randomized controlled trials are lacking. Commercial tests often overlook polygenicity and environmental factors. A positive result should not lead to self-adjustment of medication. Pharmacogenetics in reproductive medicine is an emerging field but not y","sources":[],"title":"Evidence check: Pharmakogenetik Medicheck in the context of Fruchtbarkeit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-1f5369b593cc2006e97d52f1/evidence-check-pharmakogenetik-medicheck-in-the-context-of-fruchtbarkeit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}